North America HLA Typing Transplant Diagnostics Services Market - Industry Trends Forecast to 2025
- DBMR349
- Pages: 84
- February 2018
- Total Views:1151
- Region : Global
- Data Bridge Market Research
- Market Research Report
Details
North America HLA typing transplant diagnostics services market is expected to reach USD 474.83 million by 2025, from USD 242.82 million in 2017 growing at a CAGR of 8.8% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
The major factors driving the growth of this market are technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures, risen research grants, funds, and public-private investments are boosting the growth of the North America HLA typing transplant diagnostics services market. On the other hand, weak reimbursements for organ donation and transplantation procedures, expensive NGS and PCR-based devices may hinder the growth of the market.
The key market players for North America HLA typing transplant diagnostics services market are listed below:
Proimmune Ltd.
Creative Biolabs
Histogenetics LLC
The UCLA Immunogenetics Center
Admera Health, Quick Biology
New York Blood Center
The Sequencing Center
BloodCenter of Wisconsin
Laboratory Corporation of America Holdings
One Lambda (Thermo Fischer Scientific, InC.)
The market is further segmented into:
Technology
End-User
The North America HLA typing transplant diagnostics services market is segmented based on technology into polymerase chain reaction (PCR), and next-generation sequencing (NGS). In 2018, polymerase chain reaction (PCR) segment is expected to dominate the North America HLA typing transplant diagnostics services market with 52.0% market share and is expected to reach USD 242.58 million by 2025, with a CAGR of 8.6% in the forecast period 2018 to 2025. However, Next-Generation Sequencing (NGS) is expected to grow at the highest CAGR of 9.1% in the forecast period, and is expected to reach USD 232.25 million in 2025 from USD 116.16 million in 2017.
The polymerase chain reaction (PCR) is further sub segmented on the basis of techniques into PCR-SSP (Sequence-Specific Primer), PCR SSOP (Sequence-Specific Oligonucleotide), and PCR-SBT (Sequencing Based Typing). In 2018, PCR-SSP (Sequence-Specific Primer) segment is expected to dominate the North America HLA typing transplant diagnostics services market with 43.3% market share and is expected to reach USD 199.66 million by 2025, with the CAGR of 8.4% in the forecast period 2018 to 2025. However, PCR-SBT (Sequencing Based Typing) segment is expected to grow at the highest CAGR of 9.4% in the forecast period, and is expected to reach USD 94.48 million in 2025 from USD 46.32 million in 2017.
The North America HLA typing transplant diagnostics services market is segmented on the basis of end users into hospitals, transplant centers, specialty clinics, and academic institutes. In 2018, hospitals segment is expected to dominate the North America HLA typing transplant diagnostics services market with 37.8% market share and is expected to reach USD 185.24 million by 2025, with the highest CAGR of 9.3% in the forecast period 2018 to 2025.
Based on geography, the market is segmented into:
U.S.
Canada
Mexico
Covered in this report
The report covers the present scenario and the growth prospects of the North America HLA typing transplant diagnostics services for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
Table Of Content
Scope
Table Of Contents
1. Introduction 14
1.1. Objectives Of The Study 14
1.2. Market Definition 14
1.3. Overview Of North America Hla Typing Transplant Diagnostics Services Market 14
1.4. Currency And Pricing 15
1.5. Limitation 15
1.6. Markets Covered 16
2. Market Segmentation 18
2.1. Markets Covered 18
2.2. Geographic Scope 19
2.3. Years Considered For The Study 20
2.4. Currency And Pricing 20
2.5. Research Methodology 21
2.6. Primary Interviews With Key Opinion Leaders 24
2.7. Secondary Sources 25
2.8. Assumptions 25
3. Market Overview 26
3.1. Drivers 28
3.1.1. Technological Advancements In Hla Typing 28
3.1.2. Increasing Number Of Solid Organ And Stem Cell Transplantation Procedures 29
3.1.3. Increased Research Grants, Funds, And Public-Private Investments 29
3.2. Restraints 30
3.2.1. Weak Reimbursements For Organ Donation And Transplantation Procedures 30
3.2.2. Expensive Ngs And Pcr-Based Devices 30
3.3. Opportunities 31
3.3.1. Rising Healthcare Infrastructure In Emerging Nations 31
3.4. Challenges 32
3.4.1. Significant Gap Between Number Of Organs Donated And Organs Required Annually 32
3.4.2. Lack Of Trained Staff 33
4. Executive Summary 34
5. Premium Insights 36
6. North America Hla Typing Transplant Diagnostics Services Market, By Technology 39
6.1. Overview 40
6.2. Next-Generation Sequencing (Ngs) 42
6.3. Polymerase Chain Reaction (Pcr) 43
6.3.1. Pcr Ssop (Sequence-Specific Oligonucleotide) 44
6.3.2. Pcr Ssp (Sequence-Specific Primer) 44
6.3.3. Pcr-Sbt (Sequencing Based Typing) 45
7. North America Hla Typing Transplant Diagnostics Services Market, By End-User 46
7.1. Overview 47
7.2. Specialty Clinics 49
7.3. Hospitals 50
7.4. Transplant Centers 51
7.5. Academic Institutes 52
8. North America Hla Typing Transplant Diagnostics Services Market, By Geography 53
8.1. North America 53
8.1.1. U.S. 61
8.1.2. Canada 63
8.1.3. Mexico 65
9. North America Hla Typing Transplant Diagnostics Services Market, Company Landscape 67
9.1. Company Share Analysis: North America 67
10. Company Profiles 68
10.1. Proimmune Ltd. 68
10.1.1. Company Overview 68
10.1.2. Proimmune Ltd.: Company Snapshot 68
10.1.3. Product Portfolio 69
10.1.4. Recent Developments 69
10.2. Creative Biolabs 70
10.2.1. Company Overview 70
10.2.2. Creative Biolabs: Company Snapshot 70
10.2.3. Product Portfolio 70
10.2.4. Recent Developments 70
10.3. Histogenetics Llc 71
10.3.1. Company Overview 71
10.3.2. Histogenetics Llc: Company Snapshot 71
10.3.3. Product Portfolio 71
10.3.4. Recent Developments 71
10.4. The Ucla Immunogenetics Center 72
10.4.1. Company Overview 72
10.4.2. The Ucla Immunogenetics Center: Company Snapshot 72
10.4.3. Product Portfolio 72
10.4.4. Recent Developments 72
10.5. Admera Health 73
10.5.1. Company Overview 73
10.5.2. Admera Health: Company Snapshot 73
10.5.3. Product Portfolio 74
10.5.4. Recent Developments 74
10.6. Quick Biology 75
10.6.1. Company Overview 75
10.6.2. Quick Biology: Company Snapshot 75
10.6.3. Product Portfolio 75
10.6.4. Recent Developments 75
10.7. New York Blood Center 76
10.7.1. Company Overview 76
10.7.2. New York Blood Center: Company Snapshot 76
10.7.3. Product Portfolio 76
10.7.4. Recent Developments 76
10.8. The Sequencing Center 77
10.8.1. Company Overview 77
10.8.2. The Sequencing Center: Company Snapshot 77
10.8.3. Product Portfolio 78
10.8.4. Recent Developments 78
10.9. Bloodcenter Of Wisconsin 79
10.9.1. Company Overview 79
10.9.2. Bloodcenter Of Wisconsin: Company Snapshot 79
10.9.3. Product Portfolio 79
10.9.4. Recent Developments 79
10.10. Laboratory Corporation Of America Holdings 80
10.10.1. Company Overview 80
10.10.2. Laboratory Corporation Of America Holdings: Revenue Analysis 80
10.10.3. Product Portfolio 81
10.10.4. Recent Developments 81
10.11. Thermo Fisher Scientific Inc. 82
10.11.1. Company Overview 82
10.11.2. Thermo Fisher Scientific Inc. :Revenue Analysis 82
10.11.3. Product Portfolio 83
10.11.4. Recent Developments 83
11. Related Reports 84
List Of Figure
Figures List
Figure 1 North America Hla Typing Transplant Diagnostics Services Market: Segmentation 18
Figure 2 North America Hla Typing Transplant Diagnostics Services Market: Data Triangulation 21
Figure 3 North America Hla Typing Transplant Diagnostics Services Market: Research Snapshot 22
Figure 4 North America Hla Typing Transplant Diagnostics Services Market: Bottom Up Approach 23
Figure 5 North America Hla Typing Transplant Diagnostics Services Market: Top Down Approach 23
Figure 6 North America Hla Typing Transplant Diagnostics Services Market: Interview Demographics 24
Figure 7 Drivers, Restraints, Opportunities, And Challenges Of North America Hla Typing Transplant Diagnostics Services Market 27
Figure 8 Healthcare Expenditure In Few Emerging Countries (2000, 2010 & 2014) 31
Figure 9 Number Of Donors, Recipeints And Waiting Patients In U.S. From 2010 To 2015 32
Figure 10 North America Hla Typing Transplant Diagnostics Services Market: Segmentation 35
Figure 11 Technological Advancements In Hla Typing, Increasing Number Of Solid Organ And Stem Cell Transplantation Procedures Are Expected To Drive The Market For North America Hla Typing Transplant Diagnostics Services In The Forecast Period 2018 To 2025 36
Figure 12 Polymerase Chain Reaction (Pcr) Segment Is Expected To Account For The Largest Share Of The North America Hla Typing Transplant Diagnostics Services Market In 2018 & 2025 37
Figure 13 Asia Pacific Is The Highest Growing And Most Profitable Revenue Pockets For Hla Typing Transplant Diagnostics Services Manufacturers In The Forecast Period From 2018 To 2025 38
Figure 14 North America Hla Typing Transplant Diagnostics Services Market: By Technology, 2017 40
Figure 15 North America Hla Typing Transplant Diagnostics Services Market: By End-User, 2017 47
Figure 16 North America Hla Typing Transplant Diagnostics Services Market: Snapshot (2017) 53
Figure 17 North America Hla Typing Transplant Diagnostics Services Market: By Country (2017) 55
Figure 18 North America Hla Typing Transplant Diagnostics Services Market : By Country (2018 & 2025) 56
Figure 19 North America Hla Typing Transplant Diagnostics Services Market, By Country (2017 & 2025) 57
Figure 20 North America Hla Typing Transplant Diagnostics Services Market, By Product (2018-2025) 58
Figure 21 North America Hla Typing Transplant Diagnostics Services Market: Company Share 2017 (%) 67
List Of Table
Table List
Table 1 Cost Of Different Ngs Devices 30
Table 2 North America Hla Typing Transplant Diagnostics Services Market, By Technology, 2016- 2025 (Usd Million) 41
Table 3 North America Hla Typing Transplant Diagnostics Services Market, Next-Generation Sequencing (Ngs), By Region, 2016-2025 (Usd Million) 42
Table 4 North America Hla Typing Transplant Diagnostics Services Market, Polymerase Chain Reaction (Pcr), By Technique, 2016-2025 (Usd Million) 43
Table 5 North America Hla Typing Transplant Diagnostics Services Market, Polymerase Chain Reaction (Pcr), By Region, 2016-2025 (Usd Million) 44
Table 6 North America Hla Typing Transplant Diagnostics Services Market, By End-User, 2016-2025 (Usd Million) 48
Table 7 North America Hla Typing Transplant Diagnostics Services Market, Specialty Clinics, By Region, 2016-2025 (Usd Million) 49
Table 8 North America Hla Typing Transplant Diagnostics Services Market, Hospitals, By Region, 2016-2025 (Usd Million) 50
Table 9 North America Hla Typing Transplant Diagnostics Services Market, Transplant Centers, By Region, 2016-2025 (Usd Million) 51
Table 10 North America Hla Typing Transplant Diagnostics Services Market, Academic Institutes, By Region, 2016-2025 (Usd Million) 52
Table 11 North America Hla Typing Transplant Diagnostics Services Market, By Country, 2016-2025 (Usd Million) 59
Table 12 North America Hla Typing Transplant Diagnostics Services Market By Technology, 2016-2025 (Usd Million) 59
Table 13 North America Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 60
Table 14 North America Hla Typing Transplant Diagnostics Services Market By End-User, 2016-2025 (Usd Million) 60
Table 15 U.S. Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 61
Table 16 U.S. Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 61
Table 17 U.S. Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 62
Table 18 Canada Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 63
Table 19 Canada Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 63
Table 20 Canada Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 64
Table 21 Mexico Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 65
Table 22 Mexico Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 65
Table 23 Mexico Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 66
Licence Rights
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Companies
Proimmune Ltd.
Creative Biolabs
Histogenetics LLC
The UCLA Immunogenetics Center
Admera Health, Quick Biology
New York Blood Center
The Sequencing Center
BloodCenter of Wisconsin
Laboratory Corporation of America Holdings
One Lambda (Thermo Fischer Scientific, InC.)
Company Profile
Company Profile Title
North America HLA typing transplant diagnostics services market is expected to reach USD 474.83 million by 2025, from USD 242.82 million in 2017 growing at a CAGR of 8.8% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
The major factors driving the growth of this market are technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures, risen research grants, funds, and public-private investments are boosting the growth of the North America HLA typing transplant diagnostics services market. On the other hand, weak reimbursements for organ donation and transplantation procedures, expensive NGS and PCR-based devices may hinder the growth of the market.
The key market players for North America HLA typing transplant diagnostics services market are listed below:
Proimmune Ltd.
Creative Biolabs
Histogenetics LLC
The UCLA Immunogenetics Center
Admera Health, Quick Biology
New York Blood Center
The Sequencing Center
BloodCenter of Wisconsin
Laboratory Corporation of America Holdings
One Lambda (Thermo Fischer Scientific, InC.)
The market is further segmented into:
Technology
End-User
The North America HLA typing transplant diagnostics services market is segmented based on technology into polymerase chain reaction (PCR), and next-generation sequencing (NGS). In 2018, polymerase chain reaction (PCR) segment is expected to dominate the North America HLA typing transplant diagnostics services market with 52.0% market share and is expected to reach USD 242.58 million by 2025, with a CAGR of 8.6% in the forecast period 2018 to 2025. However, Next-Generation Sequencing (NGS) is expected to grow at the highest CAGR of 9.1% in the forecast period, and is expected to reach USD 232.25 million in 2025 from USD 116.16 million in 2017.
The polymerase chain reaction (PCR) is further sub segmented on the basis of techniques into PCR-SSP (Sequence-Specific Primer), PCR SSOP (Sequence-Specific Oligonucleotide), and PCR-SBT (Sequencing Based Typing). In 2018, PCR-SSP (Sequence-Specific Primer) segment is expected to dominate the North America HLA typing transplant diagnostics services market with 43.3% market share and is expected to reach USD 199.66 million by 2025, with the CAGR of 8.4% in the forecast period 2018 to 2025. However, PCR-SBT (Sequencing Based Typing) segment is expected to grow at the highest CAGR of 9.4% in the forecast period, and is expected to reach USD 94.48 million in 2025 from USD 46.32 million in 2017.
The North America HLA typing transplant diagnostics services market is segmented on the basis of end users into hospitals, transplant centers, specialty clinics, and academic institutes. In 2018, hospitals segment is expected to dominate the North America HLA typing transplant diagnostics services market with 37.8% market share and is expected to reach USD 185.24 million by 2025, with the highest CAGR of 9.3% in the forecast period 2018 to 2025.
Based on geography, the market is segmented into:
U.S.
Canada
Mexico
Covered in this report
The report covers the present scenario and the growth prospects of the North America HLA typing transplant diagnostics services for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
Scope
Table Of Contents
1. Introduction 14
1.1. Objectives Of The Study 14
1.2. Market Definition 14
1.3. Overview Of North America Hla Typing Transplant Diagnostics Services Market 14
1.4. Currency And Pricing 15
1.5. Limitation 15
1.6. Markets Covered 16
2. Market Segmentation 18
2.1. Markets Covered 18
2.2. Geographic Scope 19
2.3. Years Considered For The Study 20
2.4. Currency And Pricing 20
2.5. Research Methodology 21
2.6. Primary Interviews With Key Opinion Leaders 24
2.7. Secondary Sources 25
2.8. Assumptions 25
3. Market Overview 26
3.1. Drivers 28
3.1.1. Technological Advancements In Hla Typing 28
3.1.2. Increasing Number Of Solid Organ And Stem Cell Transplantation Procedures 29
3.1.3. Increased Research Grants, Funds, And Public-Private Investments 29
3.2. Restraints 30
3.2.1. Weak Reimbursements For Organ Donation And Transplantation Procedures 30
3.2.2. Expensive Ngs And Pcr-Based Devices 30
3.3. Opportunities 31
3.3.1. Rising Healthcare Infrastructure In Emerging Nations 31
3.4. Challenges 32
3.4.1. Significant Gap Between Number Of Organs Donated And Organs Required Annually 32
3.4.2. Lack Of Trained Staff 33
4. Executive Summary 34
5. Premium Insights 36
6. North America Hla Typing Transplant Diagnostics Services Market, By Technology 39
6.1. Overview 40
6.2. Next-Generation Sequencing (Ngs) 42
6.3. Polymerase Chain Reaction (Pcr) 43
6.3.1. Pcr Ssop (Sequence-Specific Oligonucleotide) 44
6.3.2. Pcr Ssp (Sequence-Specific Primer) 44
6.3.3. Pcr-Sbt (Sequencing Based Typing) 45
7. North America Hla Typing Transplant Diagnostics Services Market, By End-User 46
7.1. Overview 47
7.2. Specialty Clinics 49
7.3. Hospitals 50
7.4. Transplant Centers 51
7.5. Academic Institutes 52
8. North America Hla Typing Transplant Diagnostics Services Market, By Geography 53
8.1. North America 53
8.1.1. U.S. 61
8.1.2. Canada 63
8.1.3. Mexico 65
9. North America Hla Typing Transplant Diagnostics Services Market, Company Landscape 67
9.1. Company Share Analysis: North America 67
10. Company Profiles 68
10.1. Proimmune Ltd. 68
10.1.1. Company Overview 68
10.1.2. Proimmune Ltd.: Company Snapshot 68
10.1.3. Product Portfolio 69
10.1.4. Recent Developments 69
10.2. Creative Biolabs 70
10.2.1. Company Overview 70
10.2.2. Creative Biolabs: Company Snapshot 70
10.2.3. Product Portfolio 70
10.2.4. Recent Developments 70
10.3. Histogenetics Llc 71
10.3.1. Company Overview 71
10.3.2. Histogenetics Llc: Company Snapshot 71
10.3.3. Product Portfolio 71
10.3.4. Recent Developments 71
10.4. The Ucla Immunogenetics Center 72
10.4.1. Company Overview 72
10.4.2. The Ucla Immunogenetics Center: Company Snapshot 72
10.4.3. Product Portfolio 72
10.4.4. Recent Developments 72
10.5. Admera Health 73
10.5.1. Company Overview 73
10.5.2. Admera Health: Company Snapshot 73
10.5.3. Product Portfolio 74
10.5.4. Recent Developments 74
10.6. Quick Biology 75
10.6.1. Company Overview 75
10.6.2. Quick Biology: Company Snapshot 75
10.6.3. Product Portfolio 75
10.6.4. Recent Developments 75
10.7. New York Blood Center 76
10.7.1. Company Overview 76
10.7.2. New York Blood Center: Company Snapshot 76
10.7.3. Product Portfolio 76
10.7.4. Recent Developments 76
10.8. The Sequencing Center 77
10.8.1. Company Overview 77
10.8.2. The Sequencing Center: Company Snapshot 77
10.8.3. Product Portfolio 78
10.8.4. Recent Developments 78
10.9. Bloodcenter Of Wisconsin 79
10.9.1. Company Overview 79
10.9.2. Bloodcenter Of Wisconsin: Company Snapshot 79
10.9.3. Product Portfolio 79
10.9.4. Recent Developments 79
10.10. Laboratory Corporation Of America Holdings 80
10.10.1. Company Overview 80
10.10.2. Laboratory Corporation Of America Holdings: Revenue Analysis 80
10.10.3. Product Portfolio 81
10.10.4. Recent Developments 81
10.11. Thermo Fisher Scientific Inc. 82
10.11.1. Company Overview 82
10.11.2. Thermo Fisher Scientific Inc. :Revenue Analysis 82
10.11.3. Product Portfolio 83
10.11.4. Recent Developments 83
11. Related Reports 84
List Of Figure
Figures List
Figure 1 North America Hla Typing Transplant Diagnostics Services Market: Segmentation 18
Figure 2 North America Hla Typing Transplant Diagnostics Services Market: Data Triangulation 21
Figure 3 North America Hla Typing Transplant Diagnostics Services Market: Research Snapshot 22
Figure 4 North America Hla Typing Transplant Diagnostics Services Market: Bottom Up Approach 23
Figure 5 North America Hla Typing Transplant Diagnostics Services Market: Top Down Approach 23
Figure 6 North America Hla Typing Transplant Diagnostics Services Market: Interview Demographics 24
Figure 7 Drivers, Restraints, Opportunities, And Challenges Of North America Hla Typing Transplant Diagnostics Services Market 27
Figure 8 Healthcare Expenditure In Few Emerging Countries (2000, 2010 & 2014) 31
Figure 9 Number Of Donors, Recipeints And Waiting Patients In U.S. From 2010 To 2015 32
Figure 10 North America Hla Typing Transplant Diagnostics Services Market: Segmentation 35
Figure 11 Technological Advancements In Hla Typing, Increasing Number Of Solid Organ And Stem Cell Transplantation Procedures Are Expected To Drive The Market For North America Hla Typing Transplant Diagnostics Services In The Forecast Period 2018 To 2025 36
Figure 12 Polymerase Chain Reaction (Pcr) Segment Is Expected To Account For The Largest Share Of The North America Hla Typing Transplant Diagnostics Services Market In 2018 & 2025 37
Figure 13 Asia Pacific Is The Highest Growing And Most Profitable Revenue Pockets For Hla Typing Transplant Diagnostics Services Manufacturers In The Forecast Period From 2018 To 2025 38
Figure 14 North America Hla Typing Transplant Diagnostics Services Market: By Technology, 2017 40
Figure 15 North America Hla Typing Transplant Diagnostics Services Market: By End-User, 2017 47
Figure 16 North America Hla Typing Transplant Diagnostics Services Market: Snapshot (2017) 53
Figure 17 North America Hla Typing Transplant Diagnostics Services Market: By Country (2017) 55
Figure 18 North America Hla Typing Transplant Diagnostics Services Market : By Country (2018 & 2025) 56
Figure 19 North America Hla Typing Transplant Diagnostics Services Market, By Country (2017 & 2025) 57
Figure 20 North America Hla Typing Transplant Diagnostics Services Market, By Product (2018-2025) 58
Figure 21 North America Hla Typing Transplant Diagnostics Services Market: Company Share 2017 (%) 67
List Of Table
Table List
Table 1 Cost Of Different Ngs Devices 30
Table 2 North America Hla Typing Transplant Diagnostics Services Market, By Technology, 2016- 2025 (Usd Million) 41
Table 3 North America Hla Typing Transplant Diagnostics Services Market, Next-Generation Sequencing (Ngs), By Region, 2016-2025 (Usd Million) 42
Table 4 North America Hla Typing Transplant Diagnostics Services Market, Polymerase Chain Reaction (Pcr), By Technique, 2016-2025 (Usd Million) 43
Table 5 North America Hla Typing Transplant Diagnostics Services Market, Polymerase Chain Reaction (Pcr), By Region, 2016-2025 (Usd Million) 44
Table 6 North America Hla Typing Transplant Diagnostics Services Market, By End-User, 2016-2025 (Usd Million) 48
Table 7 North America Hla Typing Transplant Diagnostics Services Market, Specialty Clinics, By Region, 2016-2025 (Usd Million) 49
Table 8 North America Hla Typing Transplant Diagnostics Services Market, Hospitals, By Region, 2016-2025 (Usd Million) 50
Table 9 North America Hla Typing Transplant Diagnostics Services Market, Transplant Centers, By Region, 2016-2025 (Usd Million) 51
Table 10 North America Hla Typing Transplant Diagnostics Services Market, Academic Institutes, By Region, 2016-2025 (Usd Million) 52
Table 11 North America Hla Typing Transplant Diagnostics Services Market, By Country, 2016-2025 (Usd Million) 59
Table 12 North America Hla Typing Transplant Diagnostics Services Market By Technology, 2016-2025 (Usd Million) 59
Table 13 North America Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 60
Table 14 North America Hla Typing Transplant Diagnostics Services Market By End-User, 2016-2025 (Usd Million) 60
Table 15 U.S. Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 61
Table 16 U.S. Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 61
Table 17 U.S. Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 62
Table 18 Canada Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 63
Table 19 Canada Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 63
Table 20 Canada Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 64
Table 21 Mexico Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 65
Table 22 Mexico Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 65
Table 23 Mexico Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 66
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Companies
Proimmune Ltd.
Creative Biolabs
Histogenetics LLC
The UCLA Immunogenetics Center
Admera Health, Quick Biology
New York Blood Center
The Sequencing Center
BloodCenter of Wisconsin
Laboratory Corporation of America Holdings
One Lambda (Thermo Fischer Scientific, InC.)
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 130 | 
January 2021
Page 156 | May 2020
Page 135 | February 2020
Page 122 | December 2019
Page 108 | December 2018